Pages that link to "Q39795545"

The following pages link to Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells (Q39795545):

Displayed 100 items.

• Expression of SCC-S2, an antiapoptotic molecule, correlates with enhanced proliferation and tumorigenicity of MDA-MB 435 cells (Q24304993) ‎ (← links)
• NF- kappa B2/p100 induces Bcl-2 expression (Q24306577) ‎ (← links)
• DJ-1 enhances cell survival through the binding of Cezanne, a negative regulator of NF-kappaB (Q24307823) ‎ (← links)
• Hodgkin's disease and the Epstein-Barr virus (Q24535291) ‎ (← links)
• Morphoproteomic confirmation of an activated nuclear factor-кBp65 pathway in follicular thyroid carcinoma (Q24630133) ‎ (← links)
• Tobacco smoking, alcohol drinking and Hodgkin's lymphoma: a European multi-centre case-control study (EPILYMPH) (Q24652677) ‎ (← links)
• Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration (Q24676501) ‎ (← links)
• Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL (Q24681342) ‎ (← links)
• Notch signaling: its roles and therapeutic potential in hematological malignancies (Q26765033) ‎ (← links)
• Epstein-Barr virus and the origin of Hodgkin lymphoma (Q26998999) ‎ (← links)
• Role of immune escape mechanisms in Hodgkin's lymphoma development and progression: a whole new world with therapeutic implications (Q27011510) ‎ (← links)
• Does the measles virus contribute to carcinogenesis? - a review (Q27026091) ‎ (← links)
• The Link between Autoimmunity and Lymphoma: Does NOTCH Signaling Play a Contributing Role? (Q28082490) ‎ (← links)
• Aberrant rel/nfkb genes and activity in human cancer (Q28140722) ‎ (← links)
• Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity (Q28142657) ‎ (← links)
• Involvement of nuclear factor-kappa B (NF-kappaB) activation in mitogen-induced lymphocyte proliferation: inhibitory effects of lymphoproliferation by salicylates acting as NF-kappaB inhibitors (Q28184300) ‎ (← links)
• To be, or not to be: NF-kappaB is the answer--role of Rel/NF-kappaB in the regulation of apoptosis (Q28190313) ‎ (← links)
• Nuclear transcription factor-kappaB as a target for cancer drug development (Q28201984) ‎ (← links)
• Hodgkin's lymphoma and CD30 signal transduction (Q28207526) ‎ (← links)
• VCP (p97) regulates NFkappaB signaling pathway, which is important for metastasis of osteosarcoma cell line (Q28211966) ‎ (← links)
• Feverfew: weeding out the root of leukaemia (Q28268808) ‎ (← links)
• Brucea javanica oil induces apoptosis in T24 bladder cancer cells via upregulation of caspase-3, caspase-9, and inhibition of NF-kappaB and COX-2 expressions (Q28283477) ‎ (← links)
• NF-kappaB and IKK as therapeutic targets in cancer (Q28297985) ‎ (← links)
• Targeting NF-kappaB in hematologic malignancies (Q28299055) ‎ (← links)
• Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity (Q28383134) ‎ (← links)
• To NFκB or not to NFκB: The Dilemma on How to Inhibit a Cancer Cell Fate Regulator (Q28386593) ‎ (← links)
• Identification of a novel Calotropis procera protein that can suppress tumor growth in breast cancer through the suppression of NF-κB pathway (Q28484477) ‎ (← links)
• IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development (Q28508430) ‎ (← links)
• The integrin alpha2beta1 agonist, aggretin, promotes proliferation and migration of VSMC through NF-kB translocation and PDGF production (Q28771350) ‎ (← links)
• NF-kappaB in cancer: from innocent bystander to major culprit (Q29614603) ‎ (← links)
• CD30+ Lymphoproliferative Disorders of the Skin (Q30235097) ‎ (← links)
• K-Ras promotes angiogenesis mediated by immortalized human pancreatic epithelial cells through mitogen-activated protein kinase signaling pathways (Q30608512) ‎ (← links)
• EBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas (Q30837949) ‎ (← links)
• Epstein-Barr virus encoded latent membrane protein 1 (LMP1) and TNF receptor associated factors (TRAF): colocalisation of LMP1 and TRAF1 in primary EBV infection and in EBV associated Hodgkin lymphoma (Q30941129) ‎ (← links)
• Mutant human cells with constitutive activation of NF-kappaB (Q31033964) ‎ (← links)
• Reactive oxygen species from NAD(P)H:quinone oxidoreductase constitutively activate NF-kappaB in malignant melanoma cells (Q31919510) ‎ (← links)
• Capsaicin suppresses phorbol ester-induced activation of NF-kappaB/Rel and AP-1 transcription factors in mouse epidermis (Q31944109) ‎ (← links)
• Gingival overgrowth as the initial paraneoplastic manifestation of Hodgkin's lymphoma in a child. A case report (Q32038456) ‎ (← links)
• Tumor necrosis factor alpha sensitizes malignant cells to chemotherapeutic drugs via the mitochondrial apoptosis pathway independently of caspase-8 and NF-kappaB. (Q33205160) ‎ (← links)
• Bystander cells and prognosis in Hodgkin lymphoma. Review based on a doctoral thesis (Q33208378) ‎ (← links)
• Basics of molecular diagnostics and therapy of malignant tumors (Q33218734) ‎ (← links)
• Hodgkin-lymphoma-derived cells show high sensitivity to dactinomycin and paclitaxel. (Q33297034) ‎ (← links)
• TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma (Q33432504) ‎ (← links)
• Characterization of anti-NF-kappaB RNA aptamer-binding specificity in vitro and in the yeast three-hybrid system (Q33495466) ‎ (← links)
• Growth suppression of mouse pituitary corticotroph tumor AtT20 cells by curcumin: a model for treating Cushing's disease (Q33559806) ‎ (← links)
• Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated death (Q33696062) ‎ (← links)
• Aspirin and other nonsteroidal anti-inflammatory drugs in relation to Hodgkin lymphoma risk in northern Denmark (Q33723545) ‎ (← links)
• Apoptosis and HIV infection: T-cells fiddle while the immune system burns (Q33762758) ‎ (← links)
• NF-kappaB as a primary regulator of the stress response (Q33771784) ‎ (← links)
• New insights into the roles of ReL/NF-kappa B transcription factors in immune function, hemopoiesis and human disease (Q33785173) ‎ (← links)
• The NF-kappaB/Rel family of transcription factors in oncogenic transformation and apoptosis (Q33791263) ‎ (← links)
• How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex (Q33797139) ‎ (← links)
• Control of apoptosis by Rel/NF-kappaB transcription factors (Q33797163) ‎ (← links)
• The molecular and cellular origins of Hodgkin's disease (Q33818404) ‎ (← links)
• Paediatric Hodgkin's disease (Q33837294) ‎ (← links)
• Oncogenic activation of NF-kappaB. (Q33849388) ‎ (← links)
• Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha. (Q33863064) ‎ (← links)
• The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance (Q33866655) ‎ (← links)
• Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway (Q33872322) ‎ (← links)
• NF-kappaB/STAT3/PI3K signaling crosstalk in iMyc E mu B lymphoma (Q33878632) ‎ (← links)
• Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategies (Q33886267) ‎ (← links)
• Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies (Q33889168) ‎ (← links)
• Kinase inhibitors in cancer therapy: a look ahead (Q33897202) ‎ (← links)
• NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. (Q33959017) ‎ (← links)
• The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). (Q33962748) ‎ (← links)
• Role of the IkappaB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells (Q33964689) ‎ (← links)
• Nuclear factor-kappa B, cancer, and apoptosis (Q34047210) ‎ (← links)
• Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia (Q34048276) ‎ (← links)
• Positive and negative regulation of apoptotic pathways by cytotoxic agents in hematological malignancies. (Q34054886) ‎ (← links)
• NF-kappaB activation in response to toxical and therapeutical agents: role in inflammation and cancer treatment (Q34088808) ‎ (← links)
• Epstein-Barr virus and Hodgkin's disease (Q34107897) ‎ (← links)
• An NAD(P)H oxidase regulates growth and transcription in melanoma cells (Q34127326) ‎ (← links)
• Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. (Q34131747) ‎ (← links)
• Regulation of constitutive p50/c-Rel activity via proteasome inhibitor-resistant IkappaBalpha degradation in B cells. (Q34182208) ‎ (← links)
• Senescence, apoptosis and therapy--cutting the lifelines of cancer. (Q34187808) ‎ (← links)
• The Reed-Sternberg cell in classical Hodgkin's disease (Q34199578) ‎ (← links)
• Epstein-Barr virus and oncogenesis: from latent genes to tumours (Q34221194) ‎ (← links)
• Hodgkin's Lymphomas: A Tumor Recognized by Its Microenvironment (Q34235750) ‎ (← links)
• Endostatin's antiangiogenic signaling network (Q34306081) ‎ (← links)
• The biology of human lymphoid malignancies revealed by gene expression profiling. (Q34313320) ‎ (← links)
• Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation (Q34338138) ‎ (← links)
• Divergent gene activation in peripheral blood and tissues of patients with rheumatoid arthritis, psoriatic arthritis and psoriasis following infliximab therapy (Q34380190) ‎ (← links)
• Ubiquitin proteasome pathway: implications and advances in cancer therapy (Q34446282) ‎ (← links)
• Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production (Q34519416) ‎ (← links)
• Profiling of Hodgkin's lymphoma cell line L1236 and germinal center B cells: identification of Hodgkin's lymphoma-specific genes (Q34520636) ‎ (← links)
• EBV in Hodgkin Lymphoma (Q34549468) ‎ (← links)
• Molecular biology of Hodgkin's lymphoma (Q34554743) ‎ (← links)
• NF-kappaB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs) (Q34560200) ‎ (← links)
• The role of Epstein-Barr virus in cancer (Q34574840) ‎ (← links)
• Growth hormone can act as a cytokine controlling survival and proliferation of immune cells: new insights into signaling pathways (Q34575948) ‎ (← links)
• Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions (Q34576340) ‎ (← links)
• Mutations in the NF-kappaB signaling pathway: implications for human disease (Q34577553) ‎ (← links)
• Unique molecular and cellular features of acute myelogenous leukemia stem cells (Q34605272) ‎ (← links)
• Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis (Q34611577) ‎ (← links)
• Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 cooperates with Myc to promote lymphoma in mice (Q34616590) ‎ (← links)
• A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma (Q34617756) ‎ (← links)
• The molecular pathogenesis of Hodgkin lymphoma. (Q34626576) ‎ (← links)
• Hodgkin lymphoma (Q34643277) ‎ (← links)
• Epstein-Barr virus-associated lymphomas. (Q34651670) ‎ (← links)
• The role of chalcones in suppression of NF-κB-mediated inflammation and cancer (Q34682265) ‎ (← links)